News Release Detail
Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund
Mylan Executive Chairman
"With this donation to The Pittsburgh Promise, we are proud to invest in the future of the region's children through enhanced educational opportunities and believe this contribution will only further build on the strength of our community and its people in the future."
Mylan CEO
Pittsburgh Promise scholars have enrolled in 91 different post-secondary public and private colleges and universities, career training companies, and vocational and trade programs throughout the Commonwealth of
Since the Pittsburgh Promise was launched in 2007,
Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com
SOURCE
News Provided by Acquire Media